IP Library Granted Patent US 10,918,883
Granted Patent B2
US 10,918,883 · App. 16/231,336 · Granted Feb 16, 2021

Systems and methods of unattended treatment

Inventors: James Boll (Auburndale, MA); Rafael Armando Sierra (Westford, MA); Elizabeth Kneen Winter (Somerville, MA); Allan Cameron (South Natick, MA); Adrian Mark West (Newton, MA); Kevin Young (Needham, MA); Bo Chen (Mountain View, CA)
Assignee: CYNOSURE, LLC
A61N5/0616A61N5/0625A61N2005/005A61N2005/063A61N2005/067A61N2005/0632A61N2005/0643A61N2005/0647A61N2005/0659A61N2005/0662
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,918,883
App. No.
16/231,336
Granted
Feb 16, 2021
Kind
B2
Abstract

In accordance with various aspects of the present teachings, systems and methods for applying treatment energy, e.g., electromagnetic radiation such as laser radiation in the visible and near infrared wavelengths, to body areas having bulges and fat deposits, loose skin, pain, acne and/or wounds. In some aspects, the systems and methods can enable relatively lengthy treatments to be performed by having the practitioner set-up and/or start the treatment, thereafter allowing the treatment to proceed safely and effectively without the continued presence of the practitioner.

Claims (29)

1. A non-invasive body tissue isolating system comprising:

a first frame comprising a first fastening member, a first skin-contacting surface, and a first applicator facing surface, wherein the first skin-contacting surface and the first applicator facing surface are opposing surfaces of the first frame, a first aperture defined by the first frame, the first aperture-comprises a first open area that ranges from about 2 cm 2 to about 150 cm 2 , the first open area extending through the first frame such that an isolated tissue region bulges through the first aperture and extends above the first skin-contacting surface when the first frame is pressed against a first body region,

the first aperture sized to isolate at least one portion of a first body region,

the first frame operable to couple a first applicator to the first body region to direct treatment energy thereto for non-invasive fat reduction;

a second frame comprising a second fastening member and a second skin-contacting surface and a second applicator facing surface, wherein the second skin-contacting surface and the second applicator facing surface are opposing surfaces of the second frame, a second aperture defined by the second frame,

the second aperture comprises a second open area that ranges from about 2 cm 2 to about 150 cm 2 , the second open area extending through the second frame such that an isolated tissue region bulges through the second aperture and extends above the second skin-contacting surface when the second frame is pressed against a second body region, the second aperture sized to isolate at least one portion of a second body region,

the second frame operable to couple a second applicator to the second body region to direct treatment energy thereto for non-invasive fat reduction; and

a connector, the first frame and the second frame connected or linked by the connector,

wherein the first aperture and the second aperture are arranged in a layout to isolate body tissue, wherein the layout facilitates altering temperature of body tissue using a non-invasive treatment system; and

wherein the system further comprising the first applicator, wherein the first fastening member attaches the first applicator to the first frame, the first applicator comprising a third skin contacting surface, the first applicator altering temperature of the at least one portion of the first body region, wherein the non-invasive treatment system comprises the first applicator.

2. The system of claim 1 further comprising the second applicator, wherein the second fastening member attaches a second applicator to the second frame, the second applicator comprising a fourth skin contacting surface, the second applicator altering temperature of the at least one portion of the second body region, wherein the non-invasive treatment system comprises the second applicator.

3. The system of claim 1 , wherein the non-invasive treatment system comprises a reservoir, wherein at least the first applicator comprises a cooling mechanism in fluid communication with the reservoir, wherein the cooling mechanism cools the third skin contacting surface.

4. The system of claim 1 , wherein at least the first applicator comprises a cooling mechanism to reduce temperature of a portion of first body region during a treatment.

5. The system of claim 1 wherein the first area and the second area range from about 2 cm 2 to 24 cm 2 .

6. The system of claim 1 wherein the first area has a first length and a first width, wherein the first length ranges from about 1 cm to about 10 cm and the first width ranges from about 2 cm to about 15 cm.

7. The system of claim 1 wherein the connector is a hinge.

8. The system of claim 7 wherein the hinge is disposed between a portion of the first frame and a portion of the second frame.

9. The system of claim 7 wherein angular orientation of first aperture and the second aperture is adjustable.

10. The system of claim 7 wherein proximity of the first aperture and the second aperture is adjustable.

11. The system of claim 1 further comprising a third frame, wherein the third frame defines a third apertures, wherein the third aperture is arranged in the layout relative to the first aperture and the second aperture.

12. The system of claim 1 wherein the first frame aligns skin contacting surface of the first applicator with the body region by fastening the first applicator to the first frame using the first fastening member, wherein the non-invasive treatment system comprises the applicator.

13. The system of claim 1 further comprising an adjustable belt coupled to the first frame and the second frame, wherein the adjustable belt secures the first frame and the second frame and presses each frame towards patient's skin.

14. The system of claim 1 wherein the layout comprises one or more of a linear pattern of apertures, a brick pattern of apertures, a vertically stacked column of apertures, and a horizontally stacked row of apertures.

15. The system of claim 1 wherein the layout comprises one or more of a linear pattern of apertures, a brick pattern of apertures, a vertically stacked column of apertures, and a horizontally stacked row of apertures, wherein the apertures comprise the first and second apertures.

16. The system of claim 1 wherein a shape of the first aperture and a shape of the second aperture are one or more of rectangle, square, circular, hexagon, and triangle.

17. The system of claim 1 wherein the first frame comprises a first short side and a first long side, the second frame comprises a second short side and a second long side.

18. The system of claim 17 further comprising a hinge, wherein the first short side is hinged to the second short side.

19. The system of claim 17 further comprising a hinge, wherein the first long side is hinged to the second long side.

20. The system of claim 1 further comprising a mask operable to attach to the first frame and occlude a portion of the first aperture during treatment using the frame.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
CHANGE OF NAME Recorded Jun 2, 2020
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 052816/0081 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
CHANGE OF NAME Recorded Mar 28, 2019
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 048726/0438 →
CHANGE OF NAME Recorded Mar 22, 2019
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 050447/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: KNEEN, ELIZABETH; CAMERON, ALLAN; WEST, ADRIAN MARK; YOUNG, KEVIN
To: CONTINUUM, LLC
Reel/Frame 048500/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: CONTINUUM LLC
To: CYNOSURE, INC.
Reel/Frame 048500/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: BOLL, JAMES; SIERRA, RAFAEL
To: CYNOSURE, INC.
Reel/Frame 048500/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: CHEN, BO
To: CYNOSURE, INC.
Reel/Frame 048501/0043 →